P Diem

Author PubWeight™ 31.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabet Med 2011 2.39
2 Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 1997 1.77
3 Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart 2005 1.61
4 Graves' ophthalmopathy: natural history and treatment outcomes. Swiss Med Wkly 2001 1.52
5 Human versus porcine insulin gone wrong. Diabetes Care 1992 1.44
6 [Immunologic studies with fully synthetic human insulin in patients with diabetes mellitus]. Schweiz Med Wochenschr 1979 1.40
7 Allergy to insulin. Br Med J 1980 1.38
8 Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991 1.28
9 Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects. Am J Physiol Regul Integr Comp Physiol 2001 1.13
10 QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia 2006 1.09
11 A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Diabetes Obes Metab 2009 0.96
12 Fuel metabolism during exercise in euglycaemia and hyperglycaemia in patients with type 1 diabetes mellitus--a prospective single-blinded randomised crossover trial. Diabetologia 2008 0.91
13 Glucose homeostasis and insulin secretion in human recipients of pancreas transplantation. Diabetes 1989 0.90
14 Apolipoprotein B as a long-term predictor of mortality in type 1 diabetes mellitus: a 15-year follow up. J Intern Med 2006 0.90
15 Treatment outcomes and mortality of 94 patients with acromegaly. Acta Neurochir (Wien) 2005 0.87
16 Activation of electrical triggers of atrial fibrillation in hyperthyroidism. J Clin Endocrinol Metab 2008 0.86
17 Microalbuminuria in diabetes mellitus: efficacy of a new screening method in comparison with timed overnight urine collection. J Diabetes Complications 2003 0.83
18 Streptozotocin-induced diabetes mellitus in pigs. Horm Metab Res 1993 0.82
19 Congenital "histiocytoid" cardiomyopathy: evidence suggesting a developmental disorder of the Purkinje cell system of the heart. Virchows Arch A Pathol Anat Histol 1982 0.82
20 Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population. Diabet Med 2009 0.80
21 [What you always wanted to know about HbA1c]. Schweiz Med Wochenschr 2000 0.80
22 [Incidence of insulin-dependent diabetes mellitus in Switzerland (1972-1993) in 19-year-old men]. Schweiz Med Wochenschr 1995 0.79
23 Sitosterolaemia in Switzerland: molecular genetics links the US Amish-Mennonites to their European roots. Clin Genet 2005 0.78
24 The effect of GH replacement therapy on different fat compartments: a whole-body magnetic resonance imaging study. Eur J Endocrinol 2010 0.78
25 [Long-term follow up after antithyroid drug treatment in Graves' disease]. Praxis (Bern 1994) 2006 0.78
26 Time-related, cross-sectional and prospective follow-up of pancreatic endocrine function after pancreas allograft transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia 1991 0.77
27 Do fully synthetic and genetically synthesised human insulin differ? Lancet 1980 0.77
28 [Hypophyseal incidentaloma in a patient with autosomal dominant polycystic kidney disease]. Praxis (Bern 1994) 2002 0.77
29 "Travelers' thyrotoxicosis" revisited. Arch Intern Med 1998 0.77
30 [Endogenous hypercortisolism and immunologically-mediated disease: three cases]. Dtsch Med Wochenschr 2005 0.76
31 Persistent microalbuminuria in adolescents with type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Results of a prospective longitudinal study. Eur J Pediatr 1994 0.75
32 Lymphocyte transformation by insulin and insulin-zinc suspensions. Clin Exp Immunol 1982 0.75
33 [Policy on diabetes nutrition 1994]. Schweiz Med Wochenschr Suppl 1994 0.75
34 [Vaccine poliomyelitis in an adult undergoing chemotherapy for non-Hodgkin lymphoma]. Schweiz Med Wochenschr 1982 0.75
35 [Treatment of hypertension in type 2 diabetes mellitus--2002 update]. Ther Umsch 2002 0.75
36 [Unspecific cellular immunity in patients with bladder cancer]. Helv Chir Acta 1982 0.75
37 Masson's papillary endothelial hyperplasia mimicking a poorly differentiated thyroid carcinoma: a case report. Eur J Endocrinol 2001 0.75
38 [Single-component insulins and synthetic human insulin: clinical observations concerning allergy, resistance and lipoatrophy]. Journ Annu Diabetol Hotel Dieu 1981 0.75
39 Delayed-type allergy to various insulin preparations. Ann Allergy 1988 0.75
40 [Determination of fructosamine in chronic kidney diseases (dialysis-dependent patients)]. Wien Klin Wochenschr Suppl 1990 0.75
41 [Prevalence of diabetes in Switzerland: calculation based on drug sales]. Schweiz Med Wochenschr 1993 0.75
42 [Calculating the basal metabolic rate and severe and morbid obesity]. Praxis (Bern 1994) 2001 0.75
43 Growth hormone regulates growth hormone receptor gene transcription in primary human thyroid cells. Mol Cell Endocrinol 2000 0.75
44 Variability in cross-reactivity of novel insulin analogues in immunometric insulin assays. Diabet Med 2009 0.75
45 [The paradox of TSH elevation in Sheehan's syndrome]. Dtsch Med Wochenschr 2002 0.75
46 Switzerland's drug surveillance. Lancet 1989 0.75
47 [An unusual IV-expert opinion]. Praxis (Bern 1994) 2003 0.75
48 Cheese turner's hypoglycaemia. Lancet 1990 0.75
49 Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency. Exp Clin Endocrinol Diabetes 2010 0.75
50 [Intensive insulin therapy--is it worth the effort?]. Ther Umsch 1995 0.75
51 [Pancreas and islet transplantation in diabetes mellitus]. Schweiz Med Wochenschr Suppl 1994 0.75
52 [Optimised glycaemic control and dose titration with insulin glargine (Lantus) by general practitioners in Switzerland: results of the OPTI-LAN Postmarketing Study]. Praxis (Bern 1994) 2009 0.75
53 [Hemolytic autoimmune anemia caused by (+)-cyanidanol-3 (Catergen)]. Schweiz Med Wochenschr 1980 0.75
54 Radio emissions and Accutrend malfunction. Diabet Med 1998 0.75
55 [Combination insulin and sulfonylurea compounds in the therapy of type II diabetes mellitus]. Schweiz Med Wochenschr 1990 0.75
56 [Endocrinology 1997]. Schweiz Med Wochenschr 1998 0.75
57 [Role of complementary medicine in type 1 diabetes mellitus in two Swiss centres]. Praxis (Bern 1994) 2009 0.75
58 No increase of IDDM incidence among Swiss military conscripts. Diabetes Care 1995 0.75